Evidence map›Paper›PMID 26035487›Full record

ReviewToxins2015

Treatment of gastrointestinal sphincters spasms with botulinum toxin A.

Giuseppe Brisinda, Nicola Sivestrini, Giuseppe Bianco, Giorgio Maria

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Therapy with botulinum neurotoxin for Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. The Role of Botox in Colorectal Disorders.Current treatment options in gastroenterology · 2018
    Review
  9. The Role of Botulinum Toxin Injections for Esophageal Motility Disorders.Current treatment options in gastroenterology · 2018
    Review
  10. Article
  11. Chronic constipation in Rome IV era: The Indian perspective.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2017
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giuseppe BrisindaDepartment of Surgery, University Hospital "Agostino Gemelli", Largo Agostino Gemelli 8, 00168 Rome, Italy. gbrisin@tin.it.
Nicola SivestriniDepartment of Surgery, University Hospital "Agostino Gemelli", Largo Agostino Gemelli 8, 00168 Rome, Italy. nicola_silvestrini@libero.it.
Giuseppe BiancoDepartment of Surgery, University Hospital "Agostino Gemelli", Largo Agostino Gemelli 8, 00168 Rome, Italy. bianco.g@live.com.
Giorgio MariaDepartment of Surgery, University Hospital "Agostino Gemelli", Largo Agostino Gemelli 8, 00168 Rome, Italy. giorgio.maria@rm.unicatt.it.
Agostino Gemelli University Polyclinic · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botulinum toxin A inhibits neuromuscular transmission. It has become a drug with many indications. The range of clinical applications has grown to encompass several neurological and non-neurological conditions. One of the most recent achievements in the field is the observation that botulinum toxin A provides benefit in diseases of the gastrointestinal tract. Although toxin blocks cholinergic nerve endings in the autonomic nervous system, it has also been shown that it does not block non-adrenergic non-cholinergic responses mediated by nitric oxide. This has promoted further interest in using botulinum toxin A as a treatment for overactive smooth muscles and sphincters. The introduction of this therapy has made the treatment of several clinical conditions easier, in the outpatient setting, at a lower cost and without permanent complications. This review presents current data on the use of botulinum toxin A in the treatment of pathological conditions of the gastrointestinal tract.

Indexed as

AnimalsBotulinum Toxins, Type AGastrointestinal DiseasesGastrointestinal TractHumansSpasmBotulinum Toxins, Type Aanusautonomic nervous system diseasesbiliary diseasesbotulinum toxinchronic constipationenteric nervous systemesophageal achalasiaesophageal diseasesexocytosisfissure-in-anogastric emptyinggastrointestinal motilitymembrane fusionmembrane proteinsneuromuscular agentsobesitypainphysiopathologyspasmtherapeutic use

Identifiers

PMID26035487
PMCPMC4488680
OpenAlexW1576204431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.